Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Virbac    VIRP   FR0000031577

VIRBAC (VIRP)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on VIRBAC
07/17 VIRBAC : 2017 second quarter consolidated sales
07/17 VIRBAC : second quarter sales growth largely offsets the decline in the first qu..
07/12VIRBAC SA : half-yearly sales release
06/23 VIRBAC : Sébastien Huron will become the new chairman of the executive board as ..
06/23 VIRBAC : Sébastien Huron will become the new chairman of the executive board as ..
06/16 VIRBAC : signs a research agreement with Bio-Gene
05/19 VIRBAC : United States selects KC Animal Health Corridor for North American dist..
05/18 VIRBAC : Availability of quarterly Financial information as of March 31st 2017
04/28 VIRBAC : Availability of annual report 2016
04/12 VIRBAC : Apr 12 - 2017 first quarter consolidated sales
04/12 VIRBAC : first quarter 2017 sales down, strongly impacted by stock effects in th..
04/07VIRBAC SA : quaterly sales release
03/13 VIRBAC : strong rebound in profitability in 2016
03/08VIRBAC SA : annual earnings release
01/17 VIRBAC : annual sales growth of 4.5%, at constant exchange rates
01/12VIRBAC SA : annual sales release
2016 VIRBAC : Oct 13 - 2016 third quarter consolidated sales
2016 VIRBAC : sales grow by 3.2% at the end of September at constant rates
2016VIRBAC SA : quaterly sales release
2016 VIRBAC : Sep 19 - 2016 half year results
2016 VIRBAC : growth of half-year results
2016 VIRBAC : Availability of the half-yearly financial report as of June 30, 2016
2016VIRBAC SA : half-yearly earnings release
2016 VIRBAC : sales grow by 3.6% at constant exchange rates in the first half
2016VIRBAC SA : half-yearly sales release
2016 VIRBAC : Declaration of the number of shares and voting rights as of June 2016, ..
2016 VIRBAC : Declaration of the number of shares and voting rights as of May 2016, 3..
2016 VIRBAC : Availability of the quarterly Financial information as of March 31,2016
2016 VIRBAC : Declaration of the number of shares and voting rights as of April 2016,..
2016 VIRBAC : Availability of Annual Financial Report 2015
2016 VIRBAC : sales in the first quarter 2016: return to organic growth
2016 VIRBAC : Declaration of the number of shares and voting rights as of March 2016,..
2016 VIRBAC : 2015 annual results heavily impacted by the United States
2016 VIRBAC : Declaration of the number of shares and voting rights as of February 20..
2016 VIRBAC : Declaration of the number of shares and voting rights as of January, 31..
2016 VIRBAC : annual sales growth of 10.2%, driven by exchange rates and acquisitions
2016 VIRBAC : Declaration of the number of shares and voting rights as of December 20..
2015 VIRBAC : Declaration of the number of shares and voting rights as of November 20..
2015 VIRBAC : Availaibility of quarterly Financial information as of September 30, 20..
2015 VIRBAC : Declaration of the number of shares and voting rights, October 2015
2015 VIRBAC : sales grow by 5.5% in the third quarter
2015 VIRBAC : Declaration of the number of shares and voting rights as of september 2..
2015 VIRBAC : 2015 half year results
2015 VIRBAC : Availability of half yearly financial report - June 2015
2015 VIRBAC : half-year results heavily impacted by the United States
2015 VIRBAC : Declaration of the number of shares and voting rights as of August 2015..
2015 VIRBAC : Declaration of the number of shares and voting rights as of July 2015, ..
2015 VIRBAC : 2015 second quarter consolidated sales
2015 VIRBAC : sales grow by 18.1% in the first half
2015 VIRBAC : Declaration of the number of shares and voting rights as of June 2015, ..
2015 VIRBAC : ex-dividend day for annual dividend
2015 VIRBAC : Group's perspectives for 2015 impacted by the industrial situation in t..
2015 VIRBAC : Group's perspectives for 2015 impacted by the industrial situation in t..
2015 VIRBAC : Declaration of the number of shares and voting rights as of May 2015, 3..
2015 VIRBAC : Availability of the quarterly financial information as of March 31, 201..
2015 VIRBAC : Declaration of the number of shares and voting rights as of April 2015,..
2015 VIRBAC : sales growth of 17.1% in the first quarter 2015
2015 VIRBAC : Declaration of the number of shares and voting rights as of March 2015,..
2015 VIRBAC : PEA-PME eligibility of Virbac
2015 VIRBAC : Results grow in 2014 following a strong second half
2015 VIRBAC : Declaration of the number of shares and voting rights as of February 20..
2015 VIRBAC : Declaration of the number of shares and voting rights as of January 201..
2015 VIRBAC : Sustained growth in the fourth quarter
2015 VIRBAC : Declaration of the number of shares and voting rights as of December 20..
2015 VIRBAC : announces the closing of the SENTINEL® brands family acquisition in the..
2014 Lilly must divest Sentinel products after FTC nod on Novartis deal
2014 VIRBAC : Declaration of the number of shares and voting rights as of November 20..
2014 VIRBAC : Availability of quarterly Financial information - September 2014
2014 VIRBAC : Declaration of the number of shares and voting rights as of October 201..
2014 VIRBAC : agrees to acquire veterinary assets from Eli Lilly in the United States
2014 VIRBAC : agrees to acquire veterinary assets from Eli Lilly in the United States
2014 VIRBAC : 2014 third quarter consolidated sales
2014 VIRBAC : confirmation of the rebound of growth in the third quarter
2014VIRBAC SA : quaterly sales release
2014 VIRBAC : Declaration of the number of shares and voting rights as of september 2..
1  2  3Next
Financials (€)
Sales 2017 901 M
EBIT 2017 79,2 M
Net income 2017 44,4 M
Debt 2017 545 M
Yield 2017 0,81%
P/E ratio 2017 28,18
P/E ratio 2018 22,42
EV / Sales 2017 1,99x
EV / Sales 2018 1,87x
Capitalization 1 252 M
Chart VIRBAC
Duration : Period :
Virbac Technical Analysis Chart | VIRP | FR0000031577 | 4-Traders
Technical analysis trends VIRBAC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 159 €
Spread / Average Target 7,4%
EPS Revisions
Managers
NameTitle
Éric Marée Chairman-Executive Board
Marie-Hélène Dick-Madelpuech Chairman-Supervisory Board
Sébastien Huron Head-Global Business Operations
Habib Ramdani Chief Financial Officer
Jeanine Dick Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
VIRBAC-11.48%1 440
ZOETIS INC16.61%30 636
JINYU BIO-TECHNOLOGY CO LTD49.34%3 206
DECHRA PHARMACEUTICALS PLC27.81%2 086
PHIBRO ANIMAL HEALTH CORP29.18%1 500
SHANGHAI HILE BIO-TECHNOLOGY CO LTD-28.00%1 224